Bortezomib is a Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Bortezomib.
| Product ID | 0409-1700_f2323114-35c2-40d0-8d41-f50fa574581d |
| NDC | 0409-1700 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bortezomib |
| Generic Name | Bortezomib |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2022-07-27 |
| Marketing Category | ANDA / |
| Application Number | ANDA208460 |
| Labeler Name | Hospira, Inc. |
| Substance Name | BORTEZOMIB |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-07-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9098 | bortezomib | bortezomib |
| 0409-1700 | Bortezomib | Bortezomib |
| 0409-1703 | BORTEZOMIB | BORTEZOMIB |
| 0409-1704 | BORTEZOMIB | BORTEZOMIB |
| 0781-3258 | bortezomib | bortezomib for injection |
| 10019-991 | BORTEZOMIB | bortezomib |
| 25021-244 | BORTEZOMIB | BORTEZOMIB |
| 43598-426 | Bortezomib | Bortexomib |
| 43598-865 | Bortezomib | Bortexomib |
| 50742-484 | Bortezomib | Bortezomib |
| 51817-586 | Bortezomib | bortezomib |
| 55150-337 | BORTEZOMIB | BORTEZOMIB |
| 60505-6050 | BORTEZOMIB | bortezomib |
| 63323-721 | Bortezomib | Bortezomib |
| 63323-821 | Bortezomib | Bortezomib |
| 67184-0530 | Bortezomib | Bortezomib |
| 68001-534 | Bortezomib | Bortezomib |
| 68001-540 | Bortezomib | Bortezomib |
| 68001-541 | Bortezomib | Bortezomib |
| 70511-161 | Bortezomib | bortezomib |
| 70511-162 | Bortezomib | bortezomib |
| 70710-1411 | BORTEZOMIB | BORTEZOMIB |
| 70771-1708 | BORTEZOMIB | BORTEZOMIB |
| 70860-225 | Bortezomib | bortezomib |
| 71288-118 | Bortezomib | Bortezomib |
| 72205-183 | Bortezomib | Bortezomib |
| 72266-243 | Bortezomib | bortezomib |
| 72266-244 | Bortezomib | bortezomib |
| 63020-049 | VELCADE | bortezomib |